Hypnosis is recommended for the management of chronic neuropathic pain, but access to this intervention remains limited due to travel distances and difficulties. This single-center, prospective, randomized exploratory study evaluated the feasibility of a hypnosis program carried out partly via telemedicine, compared with a full face-to-face program. A total of 30 eligible patients were randomized into a group of 15 patients who received three of five sessions via telemedicine and a control group of 15 patients who received all sessions in person. Primary outcomes were feasibility of the telemedicine-based hypnosis, secondary outcomes included pain score, anxiety and depressive symptoms, frequency of self-hypnosis practice, and qualitative subjective experience. Most patients (80%) completed the telemedicine program, suggesting a good feasibility. Preliminary efficacy results indicated a mean reduction of pain intensity of 2.7 (±2.0) points in the telemedicine group compared with 2.2 (±1.8) in the control group with an average difference of 0.5, 95% CI [-1.1; 2.0]. Our exploratory study suggests that the telemedicine hypnosis program is feasible for managing neuropathic pain.
No takes yet. Share an insight, caveat, or question.
Sourzac et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: